MedPath

Bronchoalveolar Immune Response Determination

Completed
Conditions
Extrinsic Allergic Alveolitis
Registration Number
NCT01237145
Lead Sponsor
Bossink, A.W.J.
Brief Summary

The purpose of this study is to establish if cells present in lung tissue during extrinsic allergic alveolitis (EAA) are able to elicit an immune response against specific antigens. The hypothesis is: cells in BAL lavage fluid from patients with EAA will be responsive to specific antigens and this response can be measured using ELISPOT.

Detailed Description

Subjects suffering from extrinsic allergic alveolitis caused by pigeons will undergo a broncho alveolar lavage. Cells obtained from this BAL will be used for ELISPOT technique with pigeon specific antigens

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • suspicion of pigeon induced extrinsic alveolitis
Exclusion Criteria
  • use of oral steroids
  • unable to give informed consent
  • age below 18

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ELISPOT response in cells obtained from broncho-alveolar lavage2 days

All elispots will be performed the same day, the end point will be available the next day

Secondary Outcome Measures
NameTimeMethod
Elispot response in cells from blood2 days

ELispots will be performed the same day as blood collection, results will be available the next day

Trial Locations

Locations (1)

Diakonessenhuis Utrecht

🇳🇱

Utrecht, Netherlands

© Copyright 2025. All Rights Reserved by MedPath